Trastuzumab: possible publication bias

Lancet. 2008 May 17;371(9625):1646-8. doi: 10.1016/S0140-6736(08)60706-0.
No abstract available

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / metabolism
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / metabolism
  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Drug Administration Schedule
  • Female
  • Humans
  • Models, Molecular
  • Publication Bias*
  • Randomized Controlled Trials as Topic
  • Receptor, ErbB-2 / metabolism
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Receptor, ErbB-2
  • Trastuzumab